SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-23-000010
Filing Date
2023-01-30
Accepted
2023-01-30 08:01:12
Documents
18
Period of Report
2023-01-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20230125.htm   iXBRL 8-K 43701
2 EX-99.1 ex991nasdaqdelistingnoti.htm EX-99.1 17970
6 ex991nasdaqdelistingnoti001.jpg GRAPHIC 235087
7 ex991nasdaqdelistingnoti002.jpg GRAPHIC 261549
8 ex991nasdaqdelistingnoti003.jpg GRAPHIC 336571
9 ex991nasdaqdelistingnoti004.jpg GRAPHIC 274701
10 ex991nasdaqdelistingnoti005.jpg GRAPHIC 29540
  Complete submission text file 0001485003-23-000010.txt   1778594

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20230125.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20230125_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20230125_pre.xml EX-101.PRE 13046
12 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20230125_htm.xml XML 11818
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 23565295
SIC: 2834 Pharmaceutical Preparations